RBC Europe’s Labcorp LH Stock Holding History

RBC Europe’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-44	Closed	-$6.6K	–	1127
2018 Q3	$6.6K	Hold	44	–	–	﹤0.01%	917
2018 Q2	$6.82K	Sell	44 -24	-35%	-$3.62K	﹤0.01%	921
2018 Q1	$9.38K	Sell	68 -4	-6%	-$588	﹤0.01%	848
2017 Q4	$9.89K	Hold	72	–	–	﹤0.01%	839
2017 Q3	$9.36K	Buy	+72	New	+$9.6K	﹤0.01%	851

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RBC Europe's LH Position: Q4 2018 in Review

RBC Europe sold out of Labcorp (LH) in Q4 2018, closing a stake of 44 shares — an estimated $6.6K sold.

RBC Europe first reported a position in LH in Q3 2017 and held it in 5 quarters. The position peaked at $9.89K in Q4 2017. 743 funds tracked by Wall St. Rank hold LH as of Q4 2018.

RBC Europe reported no remaining Labcorp position as of Q4 2018 after selling out during the quarter.
RBC Europe sold 44 Labcorp shares in Q4 2018, an estimated $6.6K.
RBC Europe first reported a position in Labcorp in Q3 2017 and held it in 5 quarters.
RBC Europe's Labcorp position peaked at $9.89K in Q4 2017.
743 funds tracked by Wall St. Rank held Labcorp as of Q4 2018.

Based on RBC Europe's 13F filing for Q4 2018, filed 9 Nov 2023.